Sequential interleukin-2 and alpha interferon for renal cell carcinoma and melanoma

This publication has 8 references indexed in Scilit:

• Is the outlook changing for patients with renal cell cancer?
  European Journal of Cancer and Clinical Oncology, 1990
• Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma
  Clinical and Experimental Immunology, 1990
• Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.
  Journal of Clinical Oncology, 1990
• An Assessment of the Current Use of Human Interferons in Therapy of Urological Cancers
  Journal of Urology, 1989
• Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.
  Journal of Clinical Oncology, 1989
• Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
  Annals of Surgery, 1989
• Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
  Cancer Treatment Reviews, 1989
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985